Device Trial Radar · NCT02910414
TARGET BP I Clinical Trial
Last checked: Nov 20, 2026Latest source record: Oct 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
300
Actual
Start
Jul 22, 2019
Primary completion
Dec 2023
Study completion May 2026
Sponsor
- Lead sponsor
- Ablative Solutions, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 22, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization.
Conditions
- Hypertension
Interventions
Dehydrated alcoholDrug
Dehydrated Alcohol Injection, USP is used in the study.
Peregrine System Kit (Sham Procedure)Device
Pre-procedural diagnostic renal angiography only, performed for confirmation of anatomical eligibility prior to randomization
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in mean systolic ABPMTime frame: 3 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Cardiology PC
Birmingham, Alabama
Piedmont Heart Institute
Atlanta, Georgia
NC Heart and Vascular Research
Raleigh, North Carolina
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.